The summary covers several cannabis and psychedelics policy updates, including conflicting industry stances on intoxicating hemp products (one group urging recriminalization, another urging regulation like alcohol), Nebraska AG's warning against buying marijuana, the Maryland task force's recommendation for phased psychedelics legalization starting with psilocybin, and FBI data showing marijuana arrests as a primary driver of drug war enforcement. Other updates include South Dakota's recommendation for tighter medical cannabis and hemp regulations, various state-level regulatory actions and new laws, and financial reports from several cannabis businesses.

Alcohol and Big Retail at Odds Over How to Handle the Intoxicating Hemp Boom

Nov 7, 2025

Source:

Tom Angell

Marijuana Moment

The cannabis landscape is currently a tug-of-war between big business and common-sense reform. Recent headlines highlight a clash over hemp-derived products: while major retail groups are pushing Congress to recriminalize them, alcohol wholesalers are surprisingly advocating for regulation and taxation instead, likely because they’ve noticed tokers are trading happy hour for flower. Meanwhile, FBI data reminds us that the "drug war" is still alive and well, with marijuana arrests still making up nearly half of all drug busts in states that haven't legalized yet. On a brighter note, Maryland is making moves toward a phased plan for legal psychedelics, starting with psilocybin.

This mix of news shows that while we’re gaining ground in places like Maryland, the fight against outdated enforcement continues elsewhere. For the average enthusiast, the push for regulation over criminalization—even from the alcohol industry—is a win for safety and accessibility. Keeping an eye on these regional shifts is vital, as these policy battles ultimately dictate whether you’re walking into a legal shop or facing an unnecessary arrest.